Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | MAOB | P27338 | 2/20 | 0.34 |
| ▸ | FLT3 | P36888 | 1/20 | 0.34 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.34 |
| ▸ | MERTK | Q12866 | 1/20 | 0.34 |
| ▸ | GAS6 | Q14393 | 1/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14511469 | 0.92 | GAA (0.35) | GAAHDAC4HDAC6KDM4EMAOB | |
| SCHEMBL8333479 | 0.86 | POLB (0.40) | HDAC4HDAC6KDM4EKMT2AHTT | |
| SCHEMBL10444901 | 0.83 | KDM4E (0.37) | GAAHDAC4HDAC6KDM4EFLT3 | |
| SCHEMBL13298035 | 0.83 | SMN1; SMN2 (0.47) | GAAHDAC6FLT3TYRO3MERTK | |
| SCHEMBL11046524 | 0.83 | MAOB (0.39) | GAAHDAC4HDAC6KDM4EMAOB | |
| SCHEMBL228314 | 0.81 | HDAC4 (0.38) | GAAHDAC4HDAC6KDM4EMAOB | |
| SCHEMBL9300620 | 0.81 | HTT (0.41) | GAAHDAC4HDAC6KDM4EMAOB | |
| SCHEMBL13508144 | 0.80 | GAA (0.41) | GAAHDAC6KDM4ESMN1; SMN2EPHX2 | |
| SCHEMBL8771887 | 0.80 | MAOB (0.37) | GAAHDAC4HDAC6KDM4EMAOB | |
| SCHEMBL13871636 | 0.79 | TSHR (0.41) | GAASMN1; SMN2EPHX2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8277695-B2 | Reversibly thermochromic compositions | BASF SE (DE) | 2012-10-02 | — | — | US | disclosed |
| US-8119778-B2 | Reversibly thermochromic compositions | BASF SE (DE) | 2012-02-21 | — | — | US | disclosed |
| US-20110180767-A1 | Reversibly thermochromic compositions | CIBA CORPORATION | 2011-07-28 | — | — | US | disclosed |
| US-7820744-B2 | Stabilizer mixtures | CIBA SPECIALTY CHEMICALS CORP. (US) | 2010-10-26 | — | — | US | disclosed |
| US-20100234494-A1 | Reversibly thermochromic compositions | CIBA CORPORATION | 2010-09-16 | — | — | US | disclosed |
| US-20100048774-A1 | STABILIZER MIXTURES | GUGUMUS FRANCOIS | 2010-02-25 | — | — | US | disclosed |
| US-20100048773-A1 | AGRICULTURAL ARTICLES | BONORA MICHELA | 2010-02-25 | — | — | US | disclosed |
| US-7628936-B2 | Mixture of steric hindred amine compound with magnesium and zinc salt; photostability; heat and oxidation resistance; for polymers | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2009-12-08 | — | — | US | disclosed |
| US-7595008-B2 | Mixture containing steric hindred amine compound with zinc and magnesium salt; photostability; heat and oxidation resistance; for polymers | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2009-09-29 | — | — | US | disclosed |
| US-20090111917-A1 | Stabilized articles | BONORA MICHELA | 2009-04-30 | — | — | US | disclosed |
| US-20090105379-A1 | Stabilizer mixtures | GUGUMUS FRANCOIS | 2009-04-23 | — | — | US | disclosed |
| US-20090093572-A1 | Stabilizer mixtures | GUGUMUS FRANCOIS | 2009-04-09 | — | — | US | disclosed |
| US-20070135537-A1 | Agricultural articles | BONORA MICHAEL | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234494-A1 | Reversibly thermochromic compositions | CRY1, REL, CRY2 | GAA 4878/4885HDAC4 2805/4885HDAC6 2649/4885 |
| US-20110180767-A1 | Reversibly thermochromic compositions | C1R, C3AR1, C9 | GAA 4667/4885HDAC4 3797/4885HDAC6 2159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.